The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genetic subtypes of large cell neuroendocrine carcinoma (LCNEC) to predict response to chemotherapy.
 
Jules Derks
No Relationships to Disclose
 
Noémie Leblay
No Relationships to Disclose
 
Robert Jan van Suylen
No Relationships to Disclose
 
Erik Thunnissen
No Relationships to Disclose
 
Michael den Bakker
No Relationships to Disclose
 
Harry J.M. Groen
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Research Funding - Lilly (Inst); Roche (Inst)
 
Egbert F. Smit
Consulting or Advisory Role - Lilly
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Roche/Genentech (Inst)
 
Ronald Damhuis
No Relationships to Disclose
 
Esther van de Broek
No Relationships to Disclose
 
Amélie Chabrier
No Relationships to Disclose
 
Matthieu Foll
No Relationships to Disclose
 
James McKay
No Relationships to Disclose
 
Lynnette Fernandez-Cuesta
Patents, Royalties, Other Intellectual Property - University of Cologne (Inst)
 
Ernst-Jan M. Speel
Honoraria - Amgen; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Anne-Marie C. Dingemans
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Clovis Oncology (Inst); Lilly (Inst); MSD Oncology (Inst); Pfizer; Roche/Genentech (Inst)